Division of Medical Microbiology, Department of Pathology, Stellenbosch University, Stellenbosch, South Africa.
Division of Medical Microbiology, Department of Pathology, Stellenbosch University, Stellenbosch, South Africa; National Health Laboratory Service, Tygerberg Hospital, Cape Town, South Africa.
Int J Antimicrob Agents. 2022 Feb;59(2):106502. doi: 10.1016/j.ijantimicag.2021.106502. Epub 2021 Dec 18.
Global antibiotic use has been increasing for decades. The gut microbiome, a key contributor to health, can be altered by antibiotics, which have been associated with both short- and long-term effects on the intestinal microbiome. The aim of this study was to summarize the effects of antibiotics on the diversity and composition of the human microbiota at different anatomical sites.
A systematic review was conducted according to PRISMA guidelines. PubMed, Scopus and Web of Science online databases were searched for studies that described the microbiome of any human bodily site pre- and post-antibiotic treatment using 16S rRNA gene sequencing. Increases or decreases in diversity, dissimilarity of microbial communities, and changes in taxonomic composition following antibiotic treatment were recorded as outcome measures.
The review identified consistent changes in the microbiota following quinolone and metronidazole treatment, and showed that combination treatment may result in longer-term dysbiosis. The importance of longitudinal analysis, and a lack of studies in paediatric populations was highlighted. Heterogeneity in the methodology of included studies could have contributed to the inconsistent findings regarding the effect of most antibiotic classes on the microbiome.
It is recommended that studies investigating the effect of antibiotics on the microbiome need to exclude participants exposed to antibiotics within 4 months preceding collection and analysis of baseline samples, and to include longitudinal analysis, particularly in the longer term. Further explorations need to be made into the functional implications of antibiotic-induced dysbiosis in the microbiome.
PROSPERO (https://www.crd.york.ac.uk/prospero; Registration:CRD42020168991).
几十年来,全球抗生素的使用一直在增加。肠道微生物群是健康的主要贡献者,抗生素会改变它,而抗生素与肠道微生物群的短期和长期影响都有关联。本研究旨在总结抗生素对不同解剖部位人体微生物群多样性和组成的影响。
根据 PRISMA 指南进行系统评价。检索了 PubMed、Scopus 和 Web of Science 在线数据库,以寻找使用 16S rRNA 基因测序描述任何人体部位抗生素治疗前后微生物组的研究。记录抗生素治疗后多样性增加或减少、微生物群落的相似性差异以及分类组成的变化作为结果衡量标准。
该综述确定了喹诺酮类和甲硝唑治疗后微生物群的一致变化,并表明联合治疗可能导致长期失调。强调了纵向分析的重要性和儿科人群研究的缺乏。纳入研究的方法学的异质性可能导致大多数抗生素类药物对微生物组影响的不一致发现。
建议研究抗生素对微生物组影响的研究需要排除在收集和分析基线样本前 4 个月内接触过抗生素的参与者,并纳入纵向分析,特别是在长期分析中。需要进一步探索抗生素诱导的微生物组失调的功能意义。
PROSPERO(https://www.crd.york.ac.uk/prospero;注册:CRD42020168991)。